One-step preparation of the engineered titanium implant by rationally designed linear fusion peptides with spacer-dependent antimicrobial, anti-inflammatory and osteogenic activities

Haoqian Xin,Junjian Chen,Tianjie Li,Guansong Hu,Zhou Fang,Haiyan Zhou,Kunzhong Guo,Lin Wang,Yingjun Wang
DOI: https://doi.org/10.1016/j.cej.2021.130380
IF: 15.1
2021-11-01
Chemical Engineering Journal
Abstract:<p>Biomaterial-associated infection (BAI) and delayed osseointegration are two major limitations for orthopeadic titanium implants, which are highly required in clinic implants. Herein, we rationally design a series of novel fusion peptides (FPs) based on HHC36 and BFP1 with different polyethylene glycol (PEG) spacers, and covalently immobilize them onto titanium implants via a one-step reaction between thiol groups and titanium hydroxyl groups. All FP-engineered implants show improved biocompatibility and osteogenic activity with <em>hBMSCs</em>. But interestingly, they display spacer-dependent antimicrobial and anti-inflammatory activities. Specifically, implants engineered with FPs containing no more than 12 units of PEG spacers exhibit strong antimicrobial activity against clinical bacteria (<em>S. aureus</em>, <em>E. coli</em>, <em>P. aeruginosa</em>, <em>S. epidermidis</em> and <em>MRSA</em>) and mediated macrophages transitions towards M2 polarization. However, implants engineered with FPs containing long PEG spacers (24 units) show negligible levels of the abovementioned activities. By all-atom molecular dynamics simulation, we demonstrate that the loss of activity is due to low exposure of antimicrobial sequence (HHC36) and high exposure of PEG. <em>In vivo</em> assays show that optimized FP-engineered implants inhibit <em>S. aureus</em> by 97.89%, while promoting osseointegration. This research provides great potential to resolve BAI and delayed osseointegration issues for orthopeadic implants.</p>
engineering, chemical, environmental
What problem does this paper attempt to address?